Bordetella pertussis
General questions
Pertussis disease
Epidemiology
Pathogenesis/virulence
Pathogenesis/virulence
100

This bacterium, Bordetella parapertussis, is classified under this Gram type based on its cell wall structure.

Gram negative

100

This is the approximate incubation period (in days) for pertussis infection.

7–10 days

100

This is a major limitation of current acellular vaccines regarding infection.

failure to prevent colonization/transmission

100

This component of the two-component regulatory system in B. pertussis functions as the sensor kinase that detects environmental signals.

BvgS

100

Pertussis toxin (PT) from Bordetella pertussis contributes to systemic effects during infection. What are the two main roles of PT in causing these systemic effects?

Induction of lymphocytosis, increases circulating lymphocytes, which is a systemic hallmark of pertussis.

Disruption of host G-protein signaling, (blocks immune cell trafficking)

200

This is the primary mode of transmission for Bordetella pertussis between individuals.

respiratory droplets

200

This characteristic “whooping” sound occurs during this phase of coughing

Paroxysmal stage

200

the two clinical forms of infection caused by Bordetella pertussis

1. acute disease (pertussis or whooping cough, mainly occurs in neonates because the first vaccine is administered at two months of age)

2. asymptomatic infection (mainly in adolescents and adults; Waning natural/aPV immunity)

200

This two-component regulatory system controls the transition between bvg+/virulent (expression of most toxins and adhesins), bvgi/intermediate (commonly associated with transmission), and bvg-/avirulent phases 

BvgAS system

200

preference site of initial attachment of B. pertussis

ciliated epithelium

300

This type of metabolism describes B. pertussis growth requirements (strict vs facultative)

aerobic

300

This stage of pertussis resembles a common cold with mild symptoms.

catarrhal stage

300

Antigens included in the aPV vaccine in USA

PTX, FHA, FIM2/3, PRN

300

This phase is characterized by high expression of toxins and adhesins in B. pertussis.

Bvg+ (virulent) phase

300

These environmental conditions (e.g., sulfate, nicotinic acid, low temperature) shift B. pertussis into this phase.

Bvg− (avirulent) phase

400

True of False. Bordetella parapertussis is known for infecting a wide range of mammals, unlike the human-restricted Bordetella pertussis.

False

400

This population is at highest risk for severe disease and mortality associated to pertussis.

infants

400

Bordetella pertussis lineage that is characterized by hyperproduction of PTX

Bordetella pertussis ptxP3 lineage
400

This major adhesin mediates attachment of B. pertussis to ciliated epithelial cells.

FHA

400

Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as

surface shield

500

These are the three main species of the genus Bordetella commonly associated with human and animal infections.

B. pertussis

B. parapertussis

B. bronchiseptica

500

Common complications in neonates infected with B. pertussis

  • Apnea
  • Pneumonia
  • Pulmonary hypertension
500

These are factors that contribute to pertussis resurgence 

Vaccine efficacy

Bacterial adaptation (>Bps, >PTX <PRN)

Lack of immunization

Incomplete vaccine coverage

500

Type of secretion system used by B. pertussis to transport PTX 

type IV secretion system


500

In Bordetella pertussis, Bps contributes to...

1. nasal mucosa attachment and colonization

2. biofilm formation

3. antimicrobial peptide resistance

4. transmission (in a mouse model of infection)